Smith & Nephew PLC SNNUF:OTCPK

RT Quote | Exchange | USD
Last | 07/01/22 EDT
13.80quote price arrow down-1.25 (-8.27%)
Volume
1,106
52 week range
13.37 - 22.57
Loading...
  • Open13.81
  • Day High13.81
  • Day Low13.81
  • Prev Close15.05
  • 52 Week High22.57
  • 52 Week High Date07/07/21
  • 52 Week Low13.37
  • 52 Week Low Date06/22/22

Key Stats

  • Market Cap12,114.61M
  • Shares Out878.19M
  • 10 Day Average Volume512
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-17.63

KEY STATS

  • Open13.81
  • Day High13.81
  • Day Low13.81
  • Prev Close15.05
  • 52 Week High22.57
  • 52 Week High Date07/07/21
  • 52 Week Low13.37
  • 52 Week Low Date06/22/22
  • Market Cap12,114.61M
  • Shares Out878.19M
  • 10 Day Average Volume512
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-17.63

RATIOS/PROFITABILITY

  • EPS (TTM)0.60
  • P/E (TTM)23.11
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date07/28/2022(est)
  • Ex Div Date03/31/2022
  • Div Amount18.40
  • Split Date-
  • Split Factor-

Latest On Smith & Nephew PLC

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. It is focused on the repair, regeneration and replacement of soft and hard tissue. The Company operates through three segments: Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints...
Roberto Quarta
Non-Executive Independent Chairman of the Board
Deepak Nath Ph.D.
Chief Executive Officer
Anne-Francoise Nesmes
Chief Financial Officer, Executive Director
Address
Building 5, Croxley Park, Hatters Lane
Watford
WD18 8YE
United Kingdom